Epitheliopathy, Acute Posterior Multifocal Placoid Pigment (APMPP) is a rare, inflammatory eye disorder that affects the retina and choroid. It is characterized by multiple, yellow-white lesions in the back of the eye that can cause vision loss. It is thought to be caused by an autoimmune reaction, and is treated with corticosteroids and immunosuppressive drugs.

The symptoms of Epitheliopathy, Acute Posterior Multifocal Placoid Pigment (APMPPP) include:

-Decreased vision

-Blurred vision

-Central or paracentral scotomas

-Photopsias

-Flashes of light

-Floaters

-Reduced color vision

-Central or paracentral visual field defects

-Macular edema

-Retinal pigment epithelium (RPE) changes

-Choroidal neovascularization

-Choroidal folds

-Choroidal atrophy

-Retinal pigment epitheliopathy (RPE) atrophy

-Retinal pigment epitheliopathy (RPE) hyperplasia

-Retinal pigment epithel

Epitheliopathy, Acute Posterior Multifocal Placoid Pigment (APMPP) is an inflammatory eye disorder that affects the retina. The exact cause of APMPP is unknown, but it is believed to be an autoimmune disorder. Possible causes of APMPP include viral infections, such as herpes simplex virus, varicella zoster virus, and cytomegalovirus; autoimmune diseases, such as systemic lupus erythematosus; and other inflammatory conditions, such as sarcoidosis. In some cases, APMPP may be associated with certain medications, such as hydroxychloroquine.

The treatment for Epitheliopathy, Acute Posterior Multifocal Placoid Pigment (APMPP) depends on the severity of the condition. Generally, treatment includes topical corticosteroids, oral corticosteroids, and immunosuppressive agents. In some cases, photodynamic therapy may be used to reduce inflammation and improve vision. In severe cases, a corneal transplant may be necessary.

The risk factors for Epitheliopathy, Acute Posterior Multifocal Placoid Pigment (APMPPP) include:

1. Age: APMPPP is more common in adults between the ages of 20 and 50.

2. Gender: APMPPP is more common in women than in men.

3. Ethnicity: APMPPP is more common in people of Asian descent.

4. Genetic predisposition: APMPPP is more common in people with a family history of the condition.

5. Systemic diseases: APMPPP is more common in people with certain systemic diseases, such as lupus, sarcoidosis, and HIV.

6. Medications: Certain medications, such as hydroxychloroquine, can increase the risk of developing APMPPP

There is no known cure for acute posterior multifocal placoid pigment epitheliopathy (APMPPE). Treatment is usually focused on managing the symptoms. This may include medications such as corticosteroids, immunosuppressants, and antiviral medications. In some cases, laser photocoagulation may be used to reduce inflammation and improve vision.